| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $54.2M | -2.7% | +18.5% |
| SG&A Expense | $17.1M | -2.1% | +31.8% |
| Operating Income | -$71.3M | +2.6% | -21.5% |
| Pre-tax Income | -$65.0M | +1.6% | -32.5% |
| Income Tax | $61K | -15.3% | — |
| Net Income | -$65.0M | +1.6% | -32.6% |
| EPS (Basic) | -$1.11 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $107.9M | -13.1% | -9.1% |
| Short-term Investments | $419.4M | +10.0% | +3.0% |
| Current Assets | $540.1M | +4.6% | +1.1% |
| Total Assets | $626.2M | -4.8% | -19.3% |
| Current Liabilities | $34.0M | +7.9% | +4.4% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$164.8M | — | — |
| Capital Expenditures | $5.1M | — | — |
| Investing Cash Flow | $109.1M | — | — |
| Financing Cash Flow | $21.5M | — | — |
| Free Cash Flow | -$169.8M | — | — |
| -29.1% |
| EPS (Diluted) | -$1.11 | +1.8% | -29.1% |
| $39.8M |
| +3.8% |
| -4.9% |
| Stockholders' Equity | $586.3M | -5.3% | -20.2% |